T1	Participants 80 158	human immunodeficiency virus-infected children and adolescents: pediatric AIDS
T2	Participants 343 395	human immunodeficiency virus (HIV)-infected children
T3	Participants 643 770	Forty-one children and youths between 5 months and 21 years with prior NRTI and no prior NNRTI or protease inhibitor experience
T4	Participants 2202 2227	NRTI-experienced children
